Iovance Biotherapeutics
IOVA
IOVA
268 hedge funds and large institutions have $6.9B invested in Iovance Biotherapeutics in 2020 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 86 increasing their positions, 97 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
6% more funds holding
Funds holding: 252 → 268 (+16)
5.83% more ownership
Funds ownership: 95.58% → 101.41% (+5.8%)
11% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 97
Holders
268
Holding in Top 10
11
Calls
$120M
Puts
$77.8M
Top Buyers
| 1 | +$343M | |
| 2 | +$230M | |
| 3 | +$79.4M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$62.1M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$42M |
Top Sellers
| 1 | -$137M | |
| 2 | -$94.5M | |
| 3 | -$42.7M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$34.4M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31.6M |